8:20 AM
Sep 20, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Colorectal cancer; leukemia

Cell culture and mouse studies suggest promoting phagocytosis mediated by CALR-asialoglycan binding could help treat colorectal cancer and leukemia. In two human colorectal cancer and two human leukemia cell lines co-cultured with...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >